Clinical Trial 46851

Garden Grove, CA 92845


Summary:

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in adult patients with a primary diagnosis of schizophrenia according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5).



  • Male or female, 18 to 60 years of age, inclusive.
  • Current diagnosis of schizophrenia according to DSM-5 criteria as determined by the modified Structured Clinical Interview for DSM-5 (modified SCID-5).
  • Diagnosis of schizophrenia for a minimum of 1 year before Visit 1.
  • Current psychotic episode < 4 weeks duration at Visit 1.
  • PANSS total score ≥ 70 and ≤ 120 at Visit 1 and Visit 2.
  • Rating of at least 4 (moderate) on at least two of the following four PANSS positive symptoms: delusions (P1), hallucinatory behavior (P3), conceptual disorganization (P2), suspiciousness/persecution (P6) at Visit 1 and Visit 2.
  • Patient must identify a caregiver who provides consent to participate in the study.
  • In the opinion of the Investigator, the patient has significant risk for suicidal behavior during the course of his/her participation in the study.


Qualified Participants May Receive:

Monetary compensation for participation.


Available At:

CNS Network - Garden Grove CA
12772 Valley View St UNIT 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.